Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Solid Tumors in Children”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Early research (Phase 1)Looking for participantsNCT06865664
What this trial is testing

FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

Who this might be right for
Rhabdomyosarcoma
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00138216
What this trial is testing

Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 42
Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01141244
What this trial is testing

Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Study completedNCT02095132
What this trial is testing

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Central Nervous System Embryonal Tumor With Rhabdoid FeaturesCentral Nervous System Embryonal Tumor, Not Otherwise SpecifiedCentral Nervous System Ganglioneuroblastoma+12 more
National Cancer Institute (NCI) 76
Early research (Phase 1)Study completedNCT00002543
What this trial is testing

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeuroblastoma+2 more
Medical College of Wisconsin 3
Testing effectiveness (Phase 2)Study completedNCT03245450
What this trial is testing

Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors

Who this might be right for
Refractory or Recurrent Solid TumorsRhabdomyosarcomaNon-Rhabdomyosarcoma Soft Tissue Sarcoma+1 more
Eisai Inc. 40
Early research (Phase 1)Study completedNCT00387920
What this trial is testing

Sunitinib in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Central Nervous System MetastasesChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal Tumor+7 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT01956669
What this trial is testing

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors

Who this might be right for
Solid Tumours
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)UnknownNCT01558453
What this trial is testing

Oxaliplatin for Children With Solid Tumors

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Sidnei Epelman 20
Testing effectiveness (Phase 2)Study completedNCT00066248
What this trial is testing

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Who this might be right for
Brain TumorCentral Nervous System TumorsCachexia+5 more
University of South Florida 70
Testing effectiveness (Phase 2)Study completedNCT00070421
What this trial is testing

Study of @neWorld: A Virtual Community for Children With Cancer

Who this might be right for
LeukemiaLymphomaPsychosocial Effects of Cancer and Its Treatment+1 more
Leap of Faith Technologies
Testing effectiveness (Phase 2)Looking for participantsNCT03838042
What this trial is testing

INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies

Who this might be right for
CNS TumorSolid Tumor
University Hospital Heidelberg 91
Early research (Phase 1)Looking for participantsNCT06500819
What this trial is testing

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

Who this might be right for
NeuroblastomaSarcomaOsteosarcoma
Stanford University 41
Early research (Phase 1)Study completedNCT00994500
What this trial is testing

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germ Cell Tumor+32 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Temporarily pausedNCT06620302
What this trial is testing

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma

Who this might be right for
Childhood Fibrolamellar CarcinomaRecurrent Childhood Fibrolamellar CarcinomaRecurrent Childhood Malignant Solid Neoplasm+6 more
Children's Oncology Group 81
Early research (Phase 1)Study completedNCT00004212
What this trial is testing

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Daiichi Sankyo